A description is given of a method of increasing the amount of stem cells and progenitor cells in circulation in the peripheral blood of a mammal the method is characterised by the administration of defibrotide in combination or in temporal proximity with at least one haematopoietic factor having the capacity to mobilise haematopoietic progenitors, preferably G-CSF.